Related Experiment Video
Updated: Jun 24, 2026
07:30
HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
Second-generation antipsychotics for schizophrenia: can we resolve the conflict?
S Leucht1, W Kissling, J M Davis
1Department of Psychiatry and Psychotherapy, Technische Universität München, Germany. Stefan.Leucht@Lrz.tu-muenchen.de
Psychological Medicine
|April 2, 2009
Summary
Second-generation antipsychotics (SGAs) are not a unified group, and expert interpretations of their effectiveness vary. Individualized treatment plans, shared with patients, are recommended due to differing drug properties.
Area of Science:
- Pharmacology
- Psychiatry
- Clinical Trials
Background:
- Initial enthusiasm for second-generation antipsychotics (SGAs) has been tempered by debate and controversial trials like CATIE, CUtLASS, and EUFEST.
- Recent meta-analyses provide updated comparisons of SGAs against placebo, conventional antipsychotics, and other SGAs.
Purpose of the Study:
- To review and synthesize findings from recent meta-analyses on second-generation antipsychotics.
- To compare these findings with previous reviews and major clinical trials.
- To critically evaluate the classification and perceived effectiveness of SGAs.
Main Methods:
- Systematic review and meta-analysis of existing studies.
- Comparison of results across multiple meta-analyses and large-scale trials (CATIE, CUtLASS, EUFEST).
Main Results:
- Second-generation antipsychotics (SGAs) are not a homogeneous class and the current classification may be misleading.
- Data interpretation varies among experts, often influenced by differing priorities (cost, side effects, efficacy) rather than solely by data.
- While SGAs are valuable treatments, they are not the revolutionary breakthrough suggested by industry.
Conclusions:
- The classification of SGAs should be reconsidered due to their diverse properties.
- Treatment decisions involving SGAs should be individualized and patient-centered.
- Despite ongoing debates, SGAs remain essential in psychiatric treatment.
Related Concept Videos
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...